U.S. FDA Says HCQ & Other Malaria Drugs in Shortage as COVID-19 Drives Up Demand
April 1 (Reuters)—The U.S. Food and Drug Administration (FDA) said malaria drugs hydroxychloroquine and related chloroquine are in shortage due to a surge in demand because of the coronavirus pandemic. The drugs, which have been tried with some success to treat the illness caused by the virus, were added to the agency’s website that lists... [Read More]
Source: The Rheumatologist - Category: Rheumatology Authors: Reuters Staff Tags: Drug Updates Drug shortage FDA HCQ Hydroxychloroquine (HCQ) U.S. Food and Drug Administration (FDA) Source Type: research
More News: Coronavirus | COVID-19 | Food and Drug Administration (FDA) | Hydroxychloroquine | Malaria | Pandemics | Rheumatology | Websites